- Home
- SNTG vs AEON Comparison
SNTG vs AEON Comparison
Compare SNTG & AEON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNTG
- AEON
- Stock Information
- Founded
- SNTG 2009
- AEON N/A
- Country
- SNTG China
- AEON United States
- Employees
- SNTG N/A
- AEON N/A
- Industry
- SNTG Finance: Consumer Services
- AEON Biotechnology: Pharmaceutical Preparations
- Sector
- SNTG Finance
- AEON Health Care
- Exchange
- SNTG Nasdaq
- AEON Nasdaq
- Market Cap
- SNTG 5.2M
- AEON 4.2M
- IPO Year
- SNTG 2021
- AEON N/A
- Fundamental
- Price
- SNTG $1.68
- AEON $0.46
- Analyst Decision
- SNTG
- AEON Strong Buy
- Analyst Count
- SNTG 0
- AEON 1
- Target Price
- SNTG N/A
- AEON $360.00
- AVG Volume (30 Days)
- SNTG 21.0K
- AEON 465.0K
- Earning Date
- SNTG 05-06-2025
- AEON 05-13-2025
- Dividend Yield
- SNTG N/A
- AEON N/A
- EPS Growth
- SNTG N/A
- AEON N/A
- EPS
- SNTG N/A
- AEON 72.93
- Revenue
- SNTG $146,472.00
- AEON N/A
- Revenue This Year
- SNTG N/A
- AEON N/A
- Revenue Next Year
- SNTG N/A
- AEON N/A
- P/E Ratio
- SNTG N/A
- AEON $0.01
- Revenue Growth
- SNTG N/A
- AEON N/A
- 52 Week Low
- SNTG $1.43
- AEON $0.38
- 52 Week High
- SNTG $3.97
- AEON $402.48
- Technical
- Relative Strength Index (RSI)
- SNTG 48.37
- AEON 26.87
- Support Level
- SNTG $1.55
- AEON $0.38
- Resistance Level
- SNTG $1.77
- AEON $0.43
- Average True Range (ATR)
- SNTG 0.10
- AEON 0.04
- MACD
- SNTG 0.01
- AEON 0.20
- Stochastic Oscillator
- SNTG 73.91
- AEON 56.29
About SNTG Sentage Holdings Inc.
Sentage Holdings Inc is a financial service provider that offers a comprehensive range of financial services across consumer loan repayment and collection management, loan recommendation, and prepaid payment network services in China.
About AEON AEON Biopharma Inc.
AEON Biopharma Inc is a clinical stage biopharmaceutical company focused on developing of its proprietary botulinum toxin complex ABP-450 (prabotulinumtoxinA) injection for debilitating medical conditions, with an initial focus on the neurosciences market.